These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 27503401
21. Effect of Botulinum Toxin A Treatment on Eyelid Pressure in Eyes with Blepharospasm. Namiguchi K, Mizoue S, Ohta K, Shiraishi A. Curr Eye Res; 2018 Jul; 43(7):896-901. PubMed ID: 29641935 [Abstract] [Full Text] [Related]
22. [The influence of sodium hyaluronate solution and artificial tears on higher-order aberrations]. Yamashita T, Ochi S, Inoue Y, Miki A, Kiryu J, Tabuchi A. Nippon Ganka Gakkai Zasshi; 2013 Dec; 117(12):963-70. PubMed ID: 24516977 [Abstract] [Full Text] [Related]
24. Objective assessment of tear film in blepharospasm, facial hemispam and aberrant regeneration with periocular botulinum toxin-A. Galindo-Ferreiro A, Fraile García M, Schellini S, Sanchez-Tocino H. Eur J Ophthalmol; 2024 Jul 26; ():11206721241266008. PubMed ID: 39056135 [Abstract] [Full Text] [Related]
25. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Ababneh OH, Cetinkaya A, Kulwin DR. Clin Exp Ophthalmol; 2014 Apr 26; 42(3):254-61. PubMed ID: 23844601 [Abstract] [Full Text] [Related]
26. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production. Ho MC, Hsu WC, Hsieh YT. JAMA Ophthalmol; 2014 Mar 26; 132(3):332-7. PubMed ID: 24385079 [Abstract] [Full Text] [Related]
27. Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study. Hirunwiwatkul P, Supawatjariyakul W, Jariyakosol S, Apinyawasisuk S, Sriratanaban J, Chongpison Y, Jagota P, Aui-Aree N, Witthayaweerasak J, Setthawatcharawanich S, Kitthaweesin K, Chirapapaisan N, Chaimongkoltrakul P, Laowanapiban P, Hansapinyo L, Panpitpat S, Kurathong S, Nimworaphan J, Thitiwichienlert S, Vanikieti K, Samipak N, Srimanan W, Mekhasingharak N, Chaitanuwong P. PLoS One; 2023 Mar 26; 18(3):e0283111. PubMed ID: 36920965 [Abstract] [Full Text] [Related]
32. Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye. Serna-Ojeda JC, Nava-Castaneda A. Acta Ophthalmol; 2017 Mar 26; 95(2):e132-e137. PubMed ID: 27350144 [Abstract] [Full Text] [Related]
33. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Koh S, Maeda N, Hirohara Y, Mihashi T, Bessho K, Hori Y, Inoue T, Watanabe H, Fujikado T, Tano Y. Invest Ophthalmol Vis Sci; 2008 Jan 26; 49(1):133-8. PubMed ID: 18172085 [Abstract] [Full Text] [Related]
34. Botulinum toxin a in the treatment of blepharospasm: a 10-year experience. Silveira-Moriyama L, Gonçalves LR, Chien HF, Barbosa ER. Arq Neuropsiquiatr; 2005 Jun 26; 63(2A):221-4. PubMed ID: 16100966 [Abstract] [Full Text] [Related]
35. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Denoyer A, Rabut G, Baudouin C. Ophthalmology; 2012 Sep 26; 119(9):1811-8. PubMed ID: 22591770 [Abstract] [Full Text] [Related]
36. Ocular surface changes following botulinum toxin injection for strabismus. Taylan Sekeroglu H, Kocabeyoglu S, Mocan MC, Muz E, Karakaya J, Irkec M, Sanac AS. Cutan Ocul Toxicol; 2015 Sep 26; 34(3):185-8. PubMed ID: 25069002 [Abstract] [Full Text] [Related]
37. Enhanced long-term potentiation-like plasticity of the trigeminal blink reflex circuit in blepharospasm. Quartarone A, Sant'Angelo A, Battaglia F, Bagnato S, Rizzo V, Morgante F, Rothwell JC, Siebner HR, Girlanda P. J Neurosci; 2006 Jan 11; 26(2):716-21. PubMed ID: 16407569 [Abstract] [Full Text] [Related]
38. A direct comparison of onabotulinumtoxina (Botox) and IncobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm: a split-face technique. Saad J, Gourdeau A. J Neuroophthalmol; 2014 Sep 11; 34(3):233-6. PubMed ID: 24739994 [Abstract] [Full Text] [Related]